# Cryptophycin payloads

Source: https://onco.cc/terms/cryptophycin-payloads/  
OnCo record `cryptophycin-payloads` (Term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Cryptophycin payloads are powerful blockers of cell division. Antibody-linked versions are being investigated to improve how these drugs reach tumors.

## Summary

Cryptophycin-55 derivatives have been attached to trastuzumab and tested in HER2-positive cell lines and mouse xenografts. Cryptophycin-52 is a tubulin inhibitor; the primary conjugate study investigated release and conversion of the cryptophycin-55 prodrug. This is an experimental tubulin-directed scaffold. Activity of the free molecule, prodrug and intact antibody conjugate must be distinguished.

## Fields

- Kind: Term
- Last checked: 2026-11-08
- Also known as: cryptophycin-55; cryptophycin-52; aza-cryptophycin payloads

## Sources

- Lai et al., cryptophycin-55/52 antibody conjugates (2020): https://doi.org/10.1016/j.ejmech.2020.112364

## Connected records

- technologies: [Antibody-drug conjugate (ADC)](https://onco.cc/technologies/adc/)
- terms: [Next-generation antibody-conjugate payloads](https://onco.cc/terms/next-generation-adc-payloads/), [Payload (ADC)](https://onco.cc/terms/payload/), [Tubulin inhibitor payloads](https://onco.cc/terms/tubulin-inhibitor-payloads/)

---
JSON: https://onco.cc/api/v1/entities/cryptophycin-payloads.json